JPRN-UMIN000034951已完成未知
Comparison of once-daily alogliptin/metformin combination tablets and twice-daily anagliptin/metformin combination tablets switching from twice-daily metformin in Japanese type 2 diabetic patients - Comparison of once-daily INISYNC combination tablets and twice-daily METOANA combination tablets LD switching from twice-daily metformin in Japanese type 2 diabetic patients
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with DPP-4 inhibitor, GLP-1 receptor agonist, or insulin therapy 2) Patients with severe renal dysfunction (eGFR <30ml/min/1.73m2) 3) Patients with severe liver dysfunction 4) Patients with severe infection, operation, trauma 5) Patients with steroid medication 6) Patients who have pregnancy or possibilty of pregnancy, or are under lactation 7) Patients who have hypersensitivity to metformin, alogliptin, or anagliptin 8) Patients who are considered to be not eligible to the study by the doctor
研究者
相似试验
招募中
不适用
Comparison of Alogliptin and Metformin fixed-dose tablets once a morning vs. once an evening using Freestyle Libre Pro flash glucose Monitoring (AMPM study): An open-label randomized cross-over Trial.Type 2 diabetesJPRN-UMIN000031445ational Hospital Organization Kyoto Medical Center20
招募中
不适用
Efficacy of alogliptin/metformin combination tablets(INISYNC combination tablets) in type 2 diabetic patients.Type 2 diabetesJPRN-UMIN000034599Minami Osaka hospital120
已完成
4 期
Comparison of Alogliptin Versus Alogliptin and Pioglitazone on Insulin Resistance of Metformin Treated Women With PCOSPolycystic Ovary SyndromeInsulin ResistanceNCT02683226University Medical Centre Ljubljana30
招募中
Unknown
Bioequivalence study of Linagliptin/metformin 2.5/1000 mg tabletThis study is performed on healthy volunteers and drug concentration in whole blood is determined..IRCT20200623047902N38Actover Co.24
尚未招募
不适用
Comparative study the use of metformin versus placebo for prophylaxis from gestational diabetes in high risk patientsNutritional, Metabolic, EndocrinePregnancy and Childbirthgestational diabetesPACTR201503001059248Tamer Mamdouh Abdel Dayem300